Preferred Label : brodalumab;
MeSH note : an anti-interleukin-17-receptor antibody for treatment of psoriasis;
MeSH hyponym : KHK4827; AMG 827;
Is substance : O;
UNII : 6ZA31Y954Z;
Origin ID : C571216;
UMLS CUI : C3491331;
ATC code(s)
Currated CISMeF NLP mapping
MeSH indexing information
MeSH term(s) associated for indexing
Pharmacological action(s)
Record concept(s)
See also (suggested by CISMeF)
See also inter- (CISMeF)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to BTNT
https://www.has-sante.fr/jcms/p_3539096/fr/kyntheum-brodalumab-biotherapies-par-voie-sous-cutanee-dans-les-maladies-inflammatoires-chroniques
2024
false
false
false
France
drug prescriptions
evaluation of the transparency committee
biological therapy
chronic disease
brodalumab
injections, subcutaneous
---
https://www.has-sante.fr/jcms/p_3363299/fr/kyntheum-brodalumab-psoriasis-en-plaques-de-l-adulte
2022
false
false
false
France
psoriasis
adult
treatment outcome
insurance, health, reimbursement
injections, subcutaneous
brodalumab
dermatologic agents
evaluation of the transparency committee
brodalumab
---
https://www.has-sante.fr/portail/jcms/c_2842284/fr/kyntheum
https://www.has-sante.fr/portail/jcms/c_2842284/fr/kyntheum-brodalumab-immunosuppresseur-inhibiteur-d-interleukines
2018
false
false
false
France
French
brodalumab
antibodies, monoclonal
brodalumab
treatment outcome
psoriasis
adult
injections, subcutaneous
Prefilled Syringe Dosage Form
receptors, interleukin-17
receptors, interleukin-17
IL17RA protein, human
insurance, health, reimbursement
evaluation of the transparency committee
guidelines for drug use
brodalumab
antibodies, monoclonal
---
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailTwo.php?lang=fr&linkID=SBD00394
2018
false
false
false
Canada
French
English
drug information
brodalumab
antibodies, monoclonal
---
https://www.ema.europa.eu/medicines/human/EPAR/Kyntheum
2017
false
false
false
United Kingdom
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
brodalumab
antibodies, monoclonal
brodalumab
drug approval
europe
treatment outcome
psoriasis
adult
injections, subcutaneous
Prefilled Syringe Dosage Form
product surveillance, postmarketing
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
receptors, interleukin-17
receptors, interleukin-17
IL17RA protein, human
brodalumab
antibodies, monoclonal
---